Michael Richman
Founder at NEXTCURE, INC.
Net worth: 524 159 $ as of 29/04/2024
Network origin in Michael Richman first degree
Entity | Entity type | Industry | |
---|---|---|---|
Chiron Corp.
Chiron Corp. Medical SpecialtiesHealth Technology Chiron Corp. provides nucleic acid test for blood screening. Its products include tigris system, target capture system, reagent preparation incubator, and many more. The company was founded in 1981 by William J. Rutter, Edward E. Penhoet & Pablo Valenzuela and is headquartered in Emeryville, CA.
43
| Extinct | Medical Specialties | 43 |
Public Company | Biotechnology | 30 | |
Opexa Therapeutics, Inc.
Opexa Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Opexa Therapeutics, Inc. engages as a biopharmaceutical company, which develops personalized immunotherapy with the potential to treat major illnesses including multiple sclerosis and other autoimmune diseases. Its product candidates include Tcelna and OPX-212. The company was founded in March 1991 and is headquartered in The Woodlands, TX.
28
| Extinct | Pharmaceuticals: Major | 28 |
Public Company | Pharmaceuticals: Major | 23 | |
MedImmune LLC
MedImmune LLC BiotechnologyHealth Technology MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD.
22
| Subsidiary | Biotechnology | 22 |
12
| Subsidiary | Pharmaceuticals: Major | 12 |
PharmaFrontiers Corp.
9
| Extinct | Pharmaceuticals: Major | 9 |
Janssen Oncology, Inc.
Janssen Oncology, Inc. Pharmaceuticals: MajorHealth Technology Janssen Oncology, Inc. engages in the development of pharmaceutical products for the treatment of cancer. It conducts pharmaceutical product trials. The company is headquartered in Los Angeles, CA.
7
| Holding Company | Pharmaceuticals: Major | 7 |
Public Company | Pharmaceuticals: Major | 7 | |
Madison Vaccines, Inc.
Madison Vaccines, Inc. Pharmaceuticals: MajorHealth Technology Madison Vaccines, Inc. develops vaccines for patients with prostate cancer. It is also developing a sensitivity test to identify those patients who will derive clinical benefit from these vaccines. The firm develops immunological therapies in patients with minimal residual disease, and for whom the mechanism of action of vaccines is ideally suited. The company was founded by Richard R. Lesniewski and Douglas G. McNeel in 2012 and is headquartered in Madison, WI.
6
| Holding Company | Pharmaceuticals: Major | 6 |
Amplimmune, Inc.
Amplimmune, Inc. BiotechnologyHealth Technology Amplimmune, Inc. develops immune-based biological treatment for cancer and autoimmune diseases. The company was founded by Michael Richman, Charles G. Drake, Andrea Cox, Drew M. Pardoll, Jonathan D. Powell, Lieping Chen, David S. Kabakoff, and Elizabeth Jaffee in 2007 and is headquartered in Gaithersburg, MD.
2
| Extinct | Biotechnology | 2 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Michael Richman via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
University of Wisconsin | College/University | Doctorate Degree Graduate Degree Undergraduate Degree Undergraduate Degree Corporate Officer/Principal | |
Cornell University
Cornell University Other Consumer ServicesConsumer Services Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY. | College/University | Undergraduate Degree Undergraduate Degree Doctorate Degree Undergraduate Degree | |
The University of Chicago | College/University | Masters Business Admin Masters Business Admin Masters Business Admin Corporate Officer/Principal | |
University of Pennsylvania | College/University | Corporate Officer/Principal Graduate Degree Undergraduate Degree | |
Human Genome Sciences, Inc.
Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD. | Medical Specialties | President Director of Finance/CFO Corporate Officer/Principal | |
University of California, Berkeley | College/University | Masters Business Admin Undergraduate Degree Graduate Degree | |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Director/Board Member Corporate Officer/Principal Corporate Officer/Principal | |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Director/Board Member | |
FIVE PRIME THERAPEUTICS, INC. | Biotechnology | Chief Executive Officer Chief Executive Officer Director/Board Member | |
University of Massachusetts | College/University | Undergraduate Degree Undergraduate Degree Corporate Officer/Principal | |
ABBOTT LABORATORIES | Medical Specialties | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
AURINIA PHARMACEUTICALS INC. | Biotechnology | Director/Board Member Chief Operating Officer Director/Board Member | |
The Johns Hopkins University | College/University | Doctorate Degree Graduate Degree Graduate Degree | |
Massachusetts Institute of Technology | College/University | Doctorate Degree Undergraduate Degree Doctorate Degree | |
Aerpio Therapeutics, Inc.
Aerpio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Aerpio Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company focused on advancing innovative therapies for vascular diseases. The firm develops small molecules and monoclonal antibodies for the treatment of vascular disease and enhancement of wound healing. Its two lead programs include a tie-2 activator for diabetic macular edema and vascular leak, and a hypoxia-inducible factor 1-a stabilizer for wound healing and the treatment of inflammatory bowel disease. The company was founded by Joseph H. Gardner and Robert Shalwitz in 2011 and is headquartered in Cincinnati, OH. | Pharmaceuticals: Major | Director/Board Member Chairman Director/Board Member | |
PRECIGEN, INC. | Biotechnology | Corporate Officer/Principal General Counsel Comptroller/Controller/Auditor | |
Arvinas Operations, Inc.
Arvinas Operations, Inc. BiotechnologyHealth Technology Arvinas Operations, Inc. develops novel therapeutics for the treatment of cancer, pro-inflammatory, autoimmune and rare diseases. It offers proteolysis-targeting chimera PROTAC-based drugs that induce protein degradation to target and eliminate disease-causing proteins from the body. The company was founded by Craig M. Crews in July 2013 and is headquartered in New Haven, CT. | Biotechnology | Chairman Director/Board Member Chief Executive Officer | |
MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal Director/Board Member Corporate Officer/Principal | |
GRITSTONE BIO, INC. | Biotechnology | Chairman Director/Board Member Director/Board Member | |
University of Michigan | College/University | Corporate Officer/Principal Masters Business Admin Undergraduate Degree | |
ARVINAS, INC. | Biotechnology | Chief Executive Officer Director/Board Member Chief Executive Officer | |
University of Maryland | College/University | Undergraduate Degree Corporate Officer/Principal Undergraduate Degree | |
Boston University | College/University | Graduate Degree Undergraduate Degree Masters Business Admin | |
Harvard Business School | College/University | Masters Business Admin Corporate Officer/Principal Masters Business Admin | |
POLYMEDIX, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Stanford University School of Medicine | College/University | Doctorate Degree Doctorate Degree | |
PROTAGONIST THERAPEUTICS, INC. | Biotechnology | Chief Tech/Sci/R&D Officer Director/Board Member | |
NEUROBO PHARMACEUTICALS, INC. | Biotechnology | Chairman Chief Executive Officer | |
SUTRO BIOPHARMA, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
University of South Florida | College/University | Undergraduate Degree Undergraduate Degree | |
Pieris Pharmaceuticals GmbH
Pieris Pharmaceuticals GmbH BiotechnologyHealth Technology Part of Pieris Pharmaceuticals, Inc., Pieris Pharmaceuticals GmbH operates as a German biotechnology company. The private company is based in Hallbergmoos, Germany. The CEOs of the company are Hitto Kaufmann, Stephen S. Yoder. | Biotechnology | Chief Executive Officer Chief Executive Officer | |
AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
BioHouston, Inc.
BioHouston, Inc. Miscellaneous Commercial ServicesCommercial Services BioHouston, Inc. engages in life science and biotechnology commercialization. The firm's mission is to create an environment that will stimulate technology transfer and research commercialization, thereby generating economic wealth for the Houston region and making it a global competitor in life science commercialization. The company is headquartered in Houston, TX. | Miscellaneous Commercial Services | Chairman Director/Board Member | |
CYTOMX THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Yale School of Medicine | College/University | Corporate Officer/Principal Corporate Officer/Principal | |
SANOFI | Miscellaneous Commercial Services | Corporate Officer/Principal Chief Operating Officer | |
Wayne State University (Michigan) | College/University | Undergraduate Degree Doctorate Degree | |
INFINITY PHARMACEUTICALS, INC. | Pharmaceuticals: Major | General Counsel Chief Tech/Sci/R&D Officer | |
TCR2 THERAPEUTICS INC. | Pharmaceuticals: Major | President Chairman | |
Bacterial Barcodes, Inc.
Bacterial Barcodes, Inc. Medical SpecialtiesHealth Technology Bacterial Barcodes, Inc. provides equipment, reagents, and software for microbial genotyping of bacteria and fungi. The company was founded on November 10, 2005 and is headquartered in Durham, NC. | Medical Specialties | Chief Executive Officer Director of Finance/CFO | |
GREENWICH LIFESCIENCES, INC. | Biotechnology | Chairman Chief Tech/Sci/R&D Officer | |
Cephalon, Inc.
Cephalon, Inc. Pharmaceuticals: MajorHealth Technology Cephalon, Inc. manufactures and distributes pharmaceutical products. It engages in the discovery and development of medicines for central nervous system disorders, pain, and cancer. The company was founded on August 24, 1987 by Frank Baldino, Jr. and is headquartered in Frazer, PA. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Director/Board Member | |
REPROS THERAPEUTICS INC | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer |
Statistics
International
United States | 46 |
Germany | 3 |
Canada | 2 |
Israel | 2 |
France | 2 |
Sectoral
Health Technology | 32 |
Consumer Services | 16 |
Commercial Services | 4 |
Finance | 2 |
Operational
Director/Board Member | 585 |
Corporate Officer/Principal | 229 |
Independent Dir/Board Member | 184 |
President | 88 |
Chairman | 86 |
Most connected contacts
Insiders | |
---|---|
Chau Khuong | 38 |
Elaine Jones | 37 |
Gregory Bailey | 36 |
Helen Kim | 33 |
David Kabakoff | 30 |
Timothy Shannon | 28 |
Edward Hurwitz | 27 |
Briggs Morrison | 26 |
Peter Kiener | 25 |
James Geraghty | 25 |
Jean Bizzari | 24 |
Darlene Deptula-Hicks | 24 |
David Hung | 24 |
Melvin Booth | 23 |
Lewis Williams | 23 |
- Stock Market
- Insiders
- Michael Richman
- Company connections